The Therapeutic Goods Administration’s (TGA) new list of medicinal cannabis products has hit some teething troubles, with companies struggling to navigate the new system.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
The list is designed to assist doctors and pharmacists in prescribing and supplying medicinal cannabis products under active ingredient categories and was published as part of the TGA’s changes to the Special Access and Authorised Prescriber schemes.